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by Elsevier B.V. This is an open accesAbstract Necrotizing sarcoid-like granulomatous disease is a disorder of unknown etiology
that is rarely described in childhood; it affects various organs and has a diverse clinical course.
Here, we report the case of a girl with multisystem recalcitrant necrotizing sarcoid-like gran-
ulomatous disease. The diagnosis is based on histopathology and the exclusion of other disease
entities known to cause granulomatous disease.
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction differentiate inflammatory granulomatous entities fromGranuloma formation is a special type of inflammation that
can occur in a wide variety of diseases, both infectious and
non-infectious. However, the offending agent is often un-
known to be sarcoidosis or granulomatous angiitis. Diag-
nosis relies on clinical history, laboratory findings
demonstrating an inflammatory process and histological
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s article under the CC BY-NC-ND ltuberculosis and other infections or malignancies [1]. The
rarity of non-infectious granulomatous disorders including
necrotizing sarcoid-like granulomatosis and the scarcity of
awareness may delay the appropriate diagnosis and treat-
ment [2,3].
We describe a girl with recalcitrant necrotizing sarcoid-
like granulomatous disease; the diagnosis is based on his-
topathology and the exclusion of other disease entities
known to cause granulomatous disease.
2. Case report
A 13-year-old Pakistani girl was referred to our hospital
with a three-year history of recurrent fever associated with
generalized body weakness and diffuse musculoskeletal
pain. She had a history of weight loss and recurrententre (General Organization), Saudi Arabia. Production and hosting
icense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
32 A. AlE’ed et al.abdominal pain without a change in bowel habits. She was
observed and evaluated in different hospitals; she had
persistently high white blood cell (WBC) and platelet counts
as well as a high erythrocyte sedimentation rate (ESR).
Other workup including bone marrow aspiration (BMA) and
cultures were negative. However, Bartonella IgG levels
were elevated. The initial clinical diagnosis was systemic
onset juvenile idiopathic arthritis. Accordingly, she was
treated with naproxen (250 mg twice daily), a high dose of
prednisone (2 mg/kg/day), methotrexate (1 mg/kg/week)
and tocilizumab (IL6 inhibitor). Because partial improve-
ment was observed, tocilizumab was switched to anakinra
(IL1 inhibitor) (100 mg daily). However, her symptoms
recurred with bloody diarrhea. Further evaluation showed
negative stool analysis and culture for any infectious dis-
ease. After undergoing upper and lower endoscopy, it was
determined that there was no ulceration, and histopathol-
ogy showed mild non-specific inflammation, which is not
consistent with inflammatory bowel disease. An abdominal
ultrasound and magnetic resonance imaging showed para-
aortic lymphadenopathy, hepatic and splenic lesions. A
lymph node biopsy revealed necrotizing granulomatous
lymphadenitis with negative culture for mycobacterial and
fungal infection. The family decided to use a mixed herbal
medicine that was a mixture of NSAIDs. There was a family
history of tuberculosis (TB).
Upon arrival to our hospital, she was febrile (38.9 C)
and appeared unwell with the same complaints mentioned
above. She had scattered lymphadenopathy, decreased air
entry bilaterally with crepitation, and hep-
atosplenomegaly. She was determined to have proximal
muscle weakness and localized thoracic vertebral tender-
ness. Another physical examination was unremarkable.
The clinical impression at that time was infection (spe-
cifically TB), Crohn’s disease, chronic granulomatous dis-
ease and autoimmune disease (namely sarcoidosis); other
diagnoses such as malignancy i.e., lymphoma were
considered as well.
The laboratory findings revealed a white blood cell count
of 19.4  109/l, hemoglobin level of 90 g/l, platelet level of
679  109/l, elevated ESR level (108 mm/h) and elevated C-
reactive protein level (213 mg/l). Her liver enzymes were
elevated (ALT 136 U/l and AST 214 U/l), Gamma-
glutamyltransferase level was GGT 104 IU/l and albuminFigure 1 Abdominal CT scan that showed multiple enlarged mese
(measured to be 12.7 cm) with multiple focal hypodense lesions; tlevel was 23 g/l. However, her renal function and muscle
enzymes were within normal range. Her complement level
(C3, C4) was normal, and her autoantibodies (antinuclear
antibodies and antineutrophil cytoplasmic antibodies) were
negative.
A chest computed tomography (CT) scan showed pleural
effusion with normal lung parenchymal tissue. However,
there were enlarged bilateral supraclavicular and para-
tracheal lymph nodes. A tuberculin skin test (TST) was
negative along with a normal QuantiFERON TB gold test.
The angiotensin-converting enzymes were borderline at
54 U/l (normal range <52). She had normal serum immu-
noglobulin levels, T and B-lymphocytes markers as well as a
normal oxidative burst assay.
She completed a capsule endoscopy, which revealed a
normal intestine.
A thoracolumbar X-ray showed multiple wedge
compression vertebral fractures and osteopenia, which
were confirmed by bone densitometry (Z-score <2).
A BMA and biopsy were negative for malignancy, granu-
lomas or infections. An abdominal CT scan confirmed mul-
tiple enlarged mesenteric and retroperitoneal lymph nodes
with multiple focal hypodense splenic lesions (Fig. 1). The
histopathology of lymph node and splenic biopsy revealed
necrotizing granulomatous inflammation (Fig. 2). An acid-
fast bacilli (AFB) stain was negative in tissue culture. A
nucleic acid amplification test using strand displacement
amplification was negative for AFB. The final report of tis-
sue culture including mycobacterial and fungal was nega-
tive. A serology (IgG and IgM) and polymerase chain
reaction (PCR) test for Bartonella was negative.
We proposed a diagnosis of systemic sarcoid-like necro-
tizing granulomatous disease especially with the presence
of necrotizing granulomatous inflammation and inconclu-
sive extensive workup, which failed to suggest an alterna-
tive diagnoses. Accordingly, we started intravenous methyl
prednisolone (30 mg/kg) weekly for four doses, oral pred-
nisone (0.5 mg/kg/day), azathioprine (2 mg/kg/day), cal-
cium and vitamin D supplements and cyclic pamidronate
(every three months) treatment. Recently, infliximab and
cyclosporine (4 mg/kg) were initiated, and she received
four doses of infliximab (5 mg/kg). Fortunately, she expe-
rienced significant clinical improvement, and her inflam-
matory markers improved as well.nteric and retroperitoneal lymph nodes (1A) and a bulky spleen
he largest was 2.2 cm in its transverse dimension (1B).
Figure 2 Histopathology of lymph node and splenic biopsy revealed ill-defined necrotizing granulomas. A shows a H&E stain of
the lymph node (20). B and C show a diff quick stain and pap stain of splenic granuloma.
Systemic sarcoid-like necrotizing granulomatous disease 333. Discussion
Non-infectious granulomatous diseases make up a hetero-
geneous group that includes sarcoidosis, granulomatous
angiitis and Crohn’s disease. Typically, affected children
experience recurrent fever and systemic manifestations.
Sarcoidosis is recognized as a systemic granulomatous
disease of unknown origin that affects various organs and
has a diverse clinical course; it is characterized by non-
necrotizing (non-caseating) granulomas [4,5]. Recently,
sarcoidosis became classified as one of the auto-
inflammatory syndromes [6]. Children younger than four
years of age typically presented with a triad of rash,
arthritis and uveitis. Sarcoidosis in older children involves
several organs, and its clinical appearance resembles the
adult type of the disease. However, patients including
children might present with necrotizing sarcoid-like gran-
ulomatous disease and an intractable clinical course
without an easily identifiable cause. Knowing that typical
clinical and laboratory findings do not exist, a definitive
diagnosis could be difficult in the presence of atypical non-
caseating granulomas [3,7,8]. Those patients encompass a
challenging group, both in terms of diagnosis and treat-
ment, as they are relatively difficult to distinguish from
typical sarcoidosis patients because of the clinical and
histologic overlap of these conditions. On the other hand,
sarcoidosis simply presents both clinically and histologically
with a variety of phenotypes [9,10].
We describe a child with periodic systemic manifesta-
tions in whom extensive investigations were inconclusive.
However, multiple histologic examinations revealed areas
of necrotizing sarcoid-like granulomas. Obviously, ourpatient does not fit into any of the distinct forms of child-
hood sarcoidosis. Nonetheless, other disease entities known
to cause granulomatous disease such as TB and Crohn’s
disease were ruled out.
Clearly, there is no permanent cure for these diseases.
However, corticosteroid remains the main stay of treat-
ment. Although the history of anti-tumor necrosis factor-a
agent use in children with sarcoidosis is limited, these drugs
may be helpful for those patients experiencing a severe and
refractory disease. We believe that our patient experi-
enced severe disease with a recalcitrant clinical course and
persistently elevated inflammatory markers. The introduc-
tion of prednisone, infliximab and methotrexate achieved
partial control of the disease.
It is not our intent to comprehensively review childhood
sarcoidosis. Rather, we suggest that the entity of idiopathic
(necrotizing sarcoid-like) granulomatous disease is on the
spectrum of sarcoidosis.Conflicts of interest
The authors declare that they have no financial or other
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